IR
63
-5
DRI
50
5
IP
42
8
NOV
58
5
HIG
56
-7
QCOM
46
2
ZBH
47
-12
HRL
47
2
PVH
64
5
HP
48
2
MSFT
40
-4
MMC
60
2
AAL
56
5
GOOG
69
2
NWSA
64
4
PYPL
50
-4
CCL
58
3
XYL
49
6
MKC
42
-3
WU
41
3
IR
63
-5
DRI
50
5
IP
42
8
NOV
58
5
HIG
56
-7
QCOM
46
2
ZBH
47
-12
HRL
47
2
PVH
64
5
HP
48
2
MSFT
40
-4
MMC
60
2
AAL
56
5
GOOG
69
2
NWSA
64
4
PYPL
50
-4
CCL
58
3
XYL
49
6
MKC
42
-3
WU
41
3
Financhill
Back

Bristol Myers Squibb Co. 10K Form

Buy
69

BMY
Bristol Myers Squibb Co.

Last Price:
$51.99
Seasonality Move:
16.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $48.3B
Cash Flow: $6B
Price / Cash Flow: 6.79
Annual Sales: $9.11
Price / Book: 5.59

Profitability

EPS (TTM): 2.96150
Net Income (TTM): $6B
Gross Margin: $27.4B
Return on Equity: 34.7%
Return on Assets: 6.43%

Bristol Myers Squibb Co. Earnings Forecast

Key Bristol Myers Squibb Co. Financial Ratios

  • The Gross Profit Margin over the past 45 years for BMY is 56.80%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 17.42% of Gross Profit Margin.
  • The Research & Development expenses have been 20.25% of Revenue.
  • The Net Earning history of BMY is -18.49% of Total Revenues.
  • Per Share Earnings over the last 45 years have been positive in 20 years.

Bristol Myers Squibb Co. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 2.75
Current Ratio: 1.27
Quick Ratio: 0.94

Price-to-Earnings

Trailing P/E Ratio: 14.88
Forward P/E Ratio: 8.51

BMY Technical Analysis vs Fundamental Analysis

Buy
69
Bristol Myers Squibb Co. (BMY) is a Buy

Is Bristol Myers Squibb Co. a Buy or a Sell?